PCSK9在新陈代谢和疾病中的作用
Amir Ajoolabady1, Domenico Pratico2, Mohsen Mazidi3
1Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Metabolism: clinical and experimental
|November 15, 2024
概括
蛋白转化酶亚素/素9型 (PCSK9) 通过控制LDL受体水平来调节胆固醇. 未经控制的PCSK9会增加LDL胆固醇,导致心血管疾病和其他疾病,突出其治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管科学 心血管科学
背景情况:
- 蛋白转化酶子素/素9型 (PCSK9) 是一种血清蛋白质酶,对于调节低密度脂蛋白 (LDL) 和胆固醇水平至关重要.
- PCSK9调解肝脏对LDL受体 (LDLR) 的内分泌体降解,影响胆固醇稳定.
- 失调的PCSK9活性导致LDL胆固醇升高,导致诸如高胆固醇血症,高脂血症和心血管疾病 (CVD) 等疾病.
研究的目的:
- 综合审查PCSK9在脂质和胆固醇代谢中的调节作用.
- 阐明PCSK9在包括心血管疾病,感染,癌症和败血症在内的疾病病理生理学的参与.
- 讨论在治疗管理中针对PCSK9的药物和非药物战略.
主要方法:
- 对现有临床和实验证据的文献综述.
- 分析PCSK9在脂质代谢和疾病发病过程中的功能.
- 探索PCSK9的代谢激素调节及其治疗影响.
主要成果:
- 通过LDLR降解,PCSK9在胆固醇调节中起着至关重要的作用.
- PCSK9与代谢异常,炎症和线粒体平衡有关.
- 代谢激素显著影响PCSK9的表达和水平,影响心血管和代谢功能.
结论:
- PCSK9是胆固醇代谢的关键调节者,对各种疾病有影响.
- 了解PCSK9的调节网络为代谢和心血管疾病提供了治疗机会.
- 向PCSK9为管理高胆固醇血症和相关疾病提供了一个有希望的策略.
相关概念视频
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
191
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
191
Factors Affecting Drug Biotransformation: Biological
116
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
116
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
32
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
32
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
87
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
87
Nonlinear Pharmacokinetics: Role of Transporters
35
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
35


